World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
33821
World Ranking
9666
National Ranking
4978

Overview

Eric D. Hsi is affiliated with the Cleveland Clinic in the United States. Their primary research contributions focus on the fields of Medicine, with specific work in Pathology and Forensic Medicine, Genetics, Oncology, Hematology, and Neurology.

The scientist's research topics include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • CNS Lymphoma Diagnosis and Treatment

Frequent co-authors collaborating with Eric D. Hsi include:

  • Govind Bhagat
  • Attilio Orazi
  • Alexandar Tzankov
  • Wayne Tam
  • Ken H. Young

Common publication venues where their work appears are:

  • Blood
  • UNC Libraries
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Journal of Clinical Oncology
  • Modern Pathology

Recent papers authored or co-authored by Eric D. Hsi include:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance, 2020, Cell Death and Disease
  • NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021, 2021, Journal of the National Comprehensive Cancer Network
  • Genomic profiling for clinical decision making in lymphoid neoplasms, 2022, Blood
  • Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma, 2020, Cancer Discovery

Best Publications

  • Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

    Anupama Reddy;Jenny Zhang;Nicholas S. Davis;Andrea B. Moffitt

  • Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

    Owen A. O'Connor;Barbara Pro;Lauren Pinter-Brown;Nancy Bartlett

  • Genetic heterogeneity of diffuse large B-cell lymphoma

    Jenny Zhang;Vladimir Grubor;Cassandra L. Love;Anjishnu Banerjee

  • The genetic landscape of mutations in Burkitt lymphoma

    Cassandra Love;Zhen Sun;Dereje Jima;Guojie Li

  • CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

    Eric D. Hsi;Roxanne Steinle;Balaji Balasa;Susann Szmania

  • MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

    Shimin Hu;Zijun Y. Xu-Monette;Alexander Tzankov;Tina Green

  • ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

    Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow

  • Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

    James L. Rubenstein;Eric D Hsi;Jeffrey L. Johnson;Sin Ho Jung

  • STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

    Andres Jerez;Michael J. Clemente;Hideki Makishima;Hanna Koskela

  • Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

    Zijun Y. Xu-Monette;Lin Wu;Carlo Visco;Yu Chuan Tai

  • MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.

    G. S. Choudhary;S. Al-Harbi;Suparna Mazumder;Brian T. Hill

  • Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.

    Jane N. Winter;Edie A. Weller;Sandra J. Horning;Maryla Krajewska

  • Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A

    Anna M. Jankowska;Hideki Makishima;Ramon V. Tiu;Hadrian Szpurka

  • Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

    Nancy L. Bartlett;Wyndham H. Wilson;Sin Ho Jung;Eric D. Hsi

  • Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study

    C Visco;Y Li;Z Y Xu-Monette;R N Miranda

  • T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates.

    E D Hsi;J N Siegel;Y Minami;E T Luong

  • US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

    Oliver W. Press;Oliver W. Press;Hongli Li;Heiko Schöder;David J. Straus

  • Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

    Hadrian Szpurka;Ramon Tiu;Gurunathan Murugesan;Samer Aboudola

  • Apo2L/TRAIL and Bcl-2–related proteins regulate type I interferon–induced apoptosis in multiple myeloma

    Quan Chen;Bendi Gong;Ashraf S. Mahmoud-Ahmed;Aimin Zhou

  • Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.

    Laszlo J. Karai;Marshall E. Kadin;Eric D. Hsi;Jason C. Sluzevich

Frequent Co-Authors

Govind Bhagat
Govind Bhagat Columbia University
Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
Youli Zu
Youli Zu Houston Methodist
Mikkael A. Sekeres
Mikkael A. Sekeres Cleveland Clinic
Santiago Montes-Moreno
Santiago Montes-Moreno Instituto de Investigación Marqués de Valdecilla
John P. Leonard
John P. Leonard Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers beyond traditional medical school, there is a growing variety of online degree programs in healthcare. Many students now pursue nursing at flexible, affordable rates thanks to options like cheap online nursing programs. These programs make it easier to enter the healthcare workforce or upskill while balancing other responsibilities.

Advancing further is possible through the cheapest rn to bsn online programs, which allow registered nurses to earn bachelor's degrees and access higher-paying roles. For those aspiring to advanced practice, the cheapest online fnp program is an effective pathway to becoming a Family Nurse Practitioner, offering leadership and patient care opportunities.

Those interested in research, education, or high-level positions can benefit from an online phd nursing program, which enhances expertise and opens new career doors. Exploring these related online degrees provides diverse entry points and progression routes in the medical and healthcare fields.

Best Scientists Citing Eric D. Hsi

Trending Scientists

Recently Published Articles